David Windley
Stock Analyst at Jefferies
(3.63)
# 804
Out of 5,131 analysts
199
Total ratings
67.54%
Success rate
14.77%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Buy | $253 → $313 | $276.85 | +13.06% | 19 | Dec 5, 2025 | |
| DEO Diageo | Downgrades: Neutral | n/a | $88.43 | - | 1 | Dec 3, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $343.98 | +18.90% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $595.00 | -24.37% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $242.41 | -7.18% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $181.38 | -3.52% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $17.39 | -45.37% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $220.91 | -11.73% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $256.82 | +2.41% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.40 | +96.43% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $46.61 | +30.87% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $17.73 | -32.32% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $278.95 | +51.28% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $181.50 | +63.64% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.61 | +517.39% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $372.83 | +62.00% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $586.24 | -36.03% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $19.20 | -19.27% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $240.12 | +12.44% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.33 | +66.13% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $275.52 | +94.54% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $21.06 | +37.70% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.46 | +3,224.40% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.02 | - | 5 | Oct 9, 2017 |
Humana
Dec 5, 2025
Upgrades: Buy
Price Target: $253 → $313
Current: $276.85
Upside: +13.06%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $88.43
Upside: -
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $343.98
Upside: +18.90%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $595.00
Upside: -24.37%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $242.41
Upside: -7.18%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $181.38
Upside: -3.52%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $17.39
Upside: -45.37%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $220.91
Upside: -11.73%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $256.82
Upside: +2.41%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.40
Upside: +96.43%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $46.61
Upside: +30.87%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.73
Upside: -32.32%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $278.95
Upside: +51.28%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $181.50
Upside: +63.64%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.61
Upside: +517.39%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $372.83
Upside: +62.00%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $586.24
Upside: -36.03%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $19.20
Upside: -19.27%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $240.12
Upside: +12.44%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.33
Upside: +66.13%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $275.52
Upside: +94.54%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $21.06
Upside: +37.70%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.46
Upside: +3,224.40%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.02
Upside: -